Annina Stauber

University Hospital Cologne

Papers

1

Total Citations

12

H-Index

1

About

Annina Stauber is a leading figure in the emerging field of cardiac radioablation, where she bridges the disciplines of radiation oncology and cardiology. Her most impactful work centers on the precise, non-invasive treatment of ventricular tachycardia, a life-threatening heart rhythm disorder. As a key contributor to the multicenter RAVENTA trial, Stauber spearheaded a critical benchmarking study that harmonized treatment planning across multiple platforms and institutions. This foundational work, which has garnered 12 citations, established the technical standards and dosimetric guidelines necessary for the safe and effective delivery of stereotactic arrhythmia radioablation (STAR). By systematically comparing planning algorithms and delivery techniques, she provided the evidence base that enables clinicians worldwide to adopt this novel therapy with confidence. Stauber’s contributions are not merely technical; they represent a paradigm shift in how we approach refractory cardiac arrhythmias, offering a non-invasive alternative to catheter ablation. Her rigorous, collaborative approach ensures that this promising treatment moves from clinical trials to standard practice with the highest standards of quality and reproducibility.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Treatment Planning for Cardiac Radioablation: Multicenter Multiplatform Benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial
12 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: University Hospital Cologne

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago